emovis by FutureMeds’ Post

We are pleased to introduce HomeConnect Trials (HCT), a leading provider of decentralised clinical trial management services.🌐 The clinical trial landscape is undergoing a transformative shift, with decentralised components becoming increasingly integral to study design. These components, such as home nursing, remote medical assessments, video visits, e-consent, and home delivery of investigational medicinal products (IMPs), 🏡🩺💻 are not merely trends, but strategic advancements aimed at enhancing patient experiences, increasing study participation, and reducing the burden on study sites.💪😊 At HCT, we specialise in managing decentralised clinical trials with a clear mission: to pioneer accessible clinical trials that enable patients to participate from the comfort of their own homes.🏠❤️ We are thrilled to embark on this new chapter and embrace the opportunities it presents. Together, let us revolutionise the way clinical trials are conducted, ensuring that we consistently meet and surpass the expectations of our valued patients.🙌🌟 We welcome the opportunity to engage with you. Please feel free to contact us at hello@hctrials.com. #HomeConnectTrials #DecentralizedClinicalTrials #PatientExperience #InnovationInHealthcare

"Stefan, what exactly does your company do?" 🤔 "We are a virtual site - one without the walls that can help sponsors and CROs expand patient access, accelerate recruitment and reduce patient burden. " ☝ "Huh...site without the walls? Sounds complicated" 😳 Actually, it's pretty simple when our experts explain it 😁 Join our webinar next week and learn why our virtual site is the future of clinical research!

Ben Baumann discusses five reasons why eConsent in clinical trials matters and why streamlining record-keeping, enhancing workflows and aligning with patient preferences helps trial sites achieve success. Give your participants what they want — digital tools for total consent management that increase understanding and engagement. Read on here: https://bit.ly/3OXS0iO #eConsent #ClinicalTrials #ClicialTrialConsent

In a new article for Applied Clinical Trials Magazine, Sandra Orset reviews trends in audit findings specific to decentralized clinical trials and provides guidance on how to develop a new project delivery framework that will support audit readiness by focusing on decentralized solutions. » https://bit.ly/3NbUuJ5 #decentralizedclinicaltrials #DCT

How do you measure implementation of patient-centric activities in a clinical trial? We share one way that we tried to gauge this, among an audience of industry, academia, healthcare organisations, and trial service providers who attended the Global Clinical Trials Connect 2024 conference. After reviewing what innovation in clinical trials means to patients, and outlining the 14 components of the 'Personalized Clinical Trials Framework' from #TransCelerate, we asked the audience which of these activities they have implemented in a clinical trial. Out of 46 respondents in the audience: 👩🎓 The highest activity implemented was providing patients education about the clinical trial (32). 💡📱The second highest activities implemented were creating general awareness about clinical trials, and enabling collection of digital data from patients during the trial (23). 🙏 Fewer had involved patients in providing input into the trial design or protocol (15). 🧓 The lowest activities were those providing patients with convenience - decentralised participation via direct delivery of therapies or alternative procedure locations, and flexibility in scheduling (7-9). There seems to be more work needed to 'walk the talk' in practice, when it comes to patient centricity in clinical trials. If trial sponsors also conducted a similar measure of their patient-centric activity implementation, we wonder what this would look like for different organisations? We welcome your thoughts and feedback! www.patient-co-next.com #patientengagement #patientcentricity #patientadvocacy #clinicaltrials #research #drugdevelopment #patientinsights #patientrecruitment #clinicaloperations #pfmd #pfdd #patientjourney #decentralizedclinicaltrials #directtopatients #personalizedclinicaltrials #patientretention #innovation #clinicaldevelopment #corvusglobalevents #measurement #implementation

DCTs hold the promise of revolutionizing the clinical trial process by improving patient engagement, recruitment, enrollment, and retention, while potentially reducing costs for sponsors, CROs, and sites. However, the road to realizing these benefits at the site level requires a concerted effort from all stakeholders. Here are some considerations for striking the balance between patient centricity and financial efficiency ⇢ https://bit.ly/3EVoRiy

[LIVE WEBINAR] Nov 28, @ 3pm CET! Patient recruitment is one of the biggest challenges in clinical studies, and a huge cause for delays... With varying study design and differences between recruitment models for pre- and post-market studies, medical device manufacturers face unique challenges in recruitment. In this webinar, we will look at how sponsors can maximize recruitment efficiencies and what the best practices for patient recruitment are in MedTech studies. Save your seat: https://bit.ly/3R1c19f #patientrecruitment #clinicaltrials #medtech #medicaldevicetrials #medicaldevices #ggclinical #greenlightguru

Today we have published a new blog post on the Allyfe website about the importance of knowing your competition in the clinical trial space. In the post, I discuss how understanding your competitors can help you to identify opportunities to differentiate your own company, improve your clinical trial process, and ultimately, improve patient outcomes. The post is based on the famous quote by Sun Tzu, "If you know the enemy and know yourself, you need not fear the result of a hundred battles." In the context of clinical trials, this means that if you understand your competitors' strengths and weaknesses, as well as your own, you will be better equipped to succeed in the competitive landscape. I hope you find this post helpful. If you have any questions, please feel free to reach out to me. https://lnkd.in/ehQ9A_ap

A few weeks ago, I attended the annual Outsourcing in Clinical Trials (OCT) conference in Barcelona. As was expected, many of the discussions highlighted the growing emphasis on patient-centric designs in clinical trials. One of the many articles that were discussed during the conference was an analysis from GlobalData. It states that "drugs developed using patient-centric designs were more likely to be launched compared to drugs developed without. It was also reported that patient-centric trials take less time to recruit patients. This indicates that optimizing patient experience leads to faster recruitment and improved retention." This got me thinking about balance. While patient-centricity obviously is crucial, it’s equally important to consider the burden on the clinics. Patient needs must be balanced with clinical support. For instance, offering home visits and flexible communication options helps patients feel more comfortable and secure, which leads to better engagement and retention. The solution is holistic. At CliniQnect, we are convinced that a holistic approach that supports both patients and clinical sites is the way forward. This includes not only practical solutions like home-based sample collections, but also providing emotional and informational support – to ensure that patients and their families feel safe and informed throughout the study. Adopting these strategies would lead to more efficient and patient-centered clinical trials, ultimately improving outcomes for all stakeholders involved: patients, clinics and study sponsors. I look forward to continuing these discussions with my industry peers during future conferences. Patrik Åvestrand, CEO #dtc #decentralized clinical trial #Remote Patient Monitoring #Clinical Research #Digital Health Solutions #Regulatory Compliance #Democratizing clinical research

Thinking ahead can save time, money, and lives when it comes to clinical trials and protocols. IRT is often an afterthought in trial planning, but thinking ahead during protocol design can be pivotal in ensuring a safe and effective trial supply. Clinical Supply Leader's Dan Schell recently got a preview of Kelsey Kern's and Irina Grishina's upcoming SCOPE presentation: Case Study: Designing the Right IRT for Direct-to-Patient and Home Treatment Studies. #clinicaltrials #clinicaltrialsupply #SCOPEsummit